Follow the instrument, entity and outcome

What is established, and what is still open?

A missing stage means it has not been established here; it does not establish non-publication or non-payment. Original firm cases · Allocation and accounting checks

Shanghai: support per eligible kWh

1,168 original proposal rows rechecked: 672 basic-support rows across 336 firms and 496 star-support rows across 124 firms. Every row's eligible kWh × rate reconciles to its amount, rounded to cents; both component totals reconcile to the published controls.

Basic and star denominators can overlap. Do not add them. Rates below are component-specific proposal amounts divided by eligible kWh, not firm revenue, realised receipts or subsidy dependence. Taxi monthly-card support and platform service costs are excluded.

Differences reflect the published facility and star-category mix. Zero-activity cells are retained; they do not identify rejected applications. The later allocation matches the programme total, without individually finalising every proposal row.

Original four-table annex · Selected component CSV · All 1,168 activity rows CSV

Procurement: supplier, brand and manufacturer

广东省粤东技师学院 · GPCGD251156HG278F

13 October 2025 award: 5,810,000.00 yuan to 浙江海天教育科技有限公司. All 21 goods lines sum to the package total. The eight lines branded 海天精工 sum to 4,871,800.00 yuan; this is part of the package, not an additional amount or established manufacturer revenue.

Brand references do not establish a contract with 宁波海天精工股份有限公司 or ownership of the supplier. Contract, acceptance and payment records remain unverified.

Original award · Saved source · Goods-line CSV

Selection evidence includes unsuccessful bidders

The award records six bidders. Five passed eligibility; one was excluded because this package was reserved for SMEs. This is a procurement eligibility finding for this lot, not a grant rejection, penalty or finding of misconduct.

Medical-device identity link with a supersession flag

The original NMGZCS-G-H-241127 schedule names 达科为（深圳）医疗设备有限公司 as manufacturer of item 1-8, cs500+dp260, valued at 330,000.00 yuan. The named supplier is 内蒙古助康药业集团有限责任公司. This matches the manufacturer's legal name in the earlier cultivation proposal; it does not confirm receipt of that grant.

Current award status unresolved. A later indexed secondary notice reports cancellation. The official correction has not been obtained; this item is excluded from realised-procurement assertions. The annex's publication date is not established from its file-storage path.

Original schedule, PDF page 2 · Saved annex and limitation · Secondary correction lead — unverified against original

科德: equity subscriptions and public participation

科德数控股份有限公司 reported 11 cash subscriptions at 70.38 yuan/share, totalling 599,999,986.62 yuan. Issuance costs of 11,996,589.45 yuan reconcile to net proceeds of 588,003,397.17 yuan. The issuer separately reports 590,999,986.82 yuan transferred to its accounts on 3 April after the underwriting deduction including tax; this differs from accounting net proceeds. Shares were registered on 15 April 2024; the 15 October lockup release is not another financing event.

Two investor profiles explicitly say 国有控股: 中国北方工业有限公司 and 银川市产业基金管理有限公司. Their subscriptions total 99,999,915.66 yuan. This is an issuer-classified subset, not a complete public-capital total. Other funds retain unresolved ownership classifications.

Equity consideration is not a grant or subsidy equivalent. No conclusion about concessional terms follows from participation. Auditor reports are cited in the issuer announcement; the underlying reports and bank records were not independently retrieved. A later sponsor opinion reproduces the eleven share allocations, corroborating the securities history rather than independently auditing cash.

Original allotment table, PDF page 7 · Sponsor follow-up, pages 2–3 · Saved issuance disclosure · Subscription CSV

Method and scope

• Purposive evidence dossiers; no sector coverage or causal effect estimate.
• Procurement consideration, equity investment and grants must not be summed into a subsidy total.
• Source-specific claims and analytical relations are separate from legal-citation edges.
• No new grant-to-bank-receipt match, authority contact or independent second human review.

Discovery: 20 Brave queries plus 19 supplementary built-in queries. Shared Brave usage at review: 352/1,000; 648 remaining. Original successful and failed retrievals are retained. Wget obtained the award and equity originals; verified-TLS fallback recovered other notice pages.